Paul Hastings

Paul Hastings

Amministratore Delegato presso NKARTA, INC.

Patrimonio netto: 1 M $ in data 31/05/2026

66 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Paul J.
Hastings
is the founder of Termeer Foundation, established in 2023, serving as Director.
Current jobs include Chief Executive Officer & Director at Nkarta, Inc. since 2024, Chairman at Specific Biologics, Inc. starting 2025, Director at Pacira Pharmaceuticals, Inc. (California), Director at California Biomedical Innovation Alliance, Director at California Life Sciences Association since 2013, and Independent Director at enGene Therapeutics, Inc. since 2024.
Former jobs include President & Chief Executive Officer at LXR Biotechnology, Inc. (1998–1999), President & Chief Executive Officer at Axys Pharmaceuticals, Inc. (2000–2002), President & Chief Executive Officer at QLT, Inc. (2002–2006), Chairman, President & Chief Executive Officer at Mereo BioPharma 5, Inc. (2013–2018), Chairman at Proteon Therapeutics, Inc., Vice Chairman at Biotechnology Innovation Organization, Chairman at Proteolix, Inc. (2008–2009), Chairman at Pacira Biosciences, Inc. (2024–2025), Director at ViaCell, Inc. (2000–2007), Director at Arriva Pharmaceuticals, Inc., Director at ViaCyte, Inc., Director at Cerimon Pharmaceuticals, Inc., Director at California Healthcare Institute, Director at The Bay Area Bioscience Association, Independent Director at Relypsa, Inc. (2013–2016), GM-European Division, VP-Sales & Marketing at Synergen, Inc., President-Worldwide Therapeutics at Genzyme Corp.
(1994–1998), Principal at Hoffmann-La Roche, Inc., and President at CHIRON Biopharmaceuticals (1999–2001).
Education includes undergraduate degree from the University of Rhode Island, conferred in 1984.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
18/06/2026 390.247 ( 0,55% ) 1 M $ 31/05/2026
16/06/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Paul Hastings

SocietàPosizioneInizio
NKARTA, INC. Amministratore Delegato 01/02/2018
ENGENE THERAPEUTICS INC. Direttore/Membro del Consiglio 15/05/2024
Fondatore 01/06/2023
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/01/2013
Direttore/Membro del Consiglio -
Presidente 11/06/2025

Precedenti posizioni note di Paul Hastings

SocietàPosizioneFine
PACIRA BIOSCIENCES, INC. Presidente 28/01/2025
ONCOMED PHARMACEUTICALS INC Amministratore Delegato 01/01/2018
░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Paul Hastings

Formazione di Paul Hastings

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

74

Relazioni di 1° grado

27

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private27

Health Technology

Utilities

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

CHIRON Biopharmaceuticals

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

  1. Mercati
  2. Insiders
  3. Paul Hastings
-40%: Proroga eccezionale
g
:
:
ENTRA ORA